EUR 0.3
(7.19%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -11.5 Million EUR | -148.83% |
2022 | 23.55 Million EUR | 225.69% |
2021 | 7.23 Million EUR | -43.96% |
2020 | 12.9 Million EUR | 0.0% |
2019 | - EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q1 | -2478.50 EUR | 40.8% |
2023 FY | -11.5 Million EUR | -148.83% |
2023 Q2 | -2478.50 EUR | 0.0% |
2022 FY | 23.55 Million EUR | 225.69% |
2022 Q4 | -4186.50 EUR | 0.0% |
2021 FY | 7.23 Million EUR | -43.96% |
2020 FY | 12.9 Million EUR | 0.0% |
2019 FY | - EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
European Medical Solutions | 13.51 Million EUR | 185.138% |
FERMENTALG | 535 Thousand EUR | 2250.093% |
PHAXIAM Therapeutics S.A. | 1.32 Million EUR | 967.496% |